Ophthalmic artery changes in type 2 diabetes with and without acute coronary syndrome
Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic hea...
Saved in:
Published in | Journal of translational medicine Vol. 20; no. 1; pp. 512 - 10 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
05.11.2022
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS).
In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA.
In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters.
This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA. |
---|---|
AbstractList | Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS).
In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA.
In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters.
This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA. Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS).BACKGROUNDOcular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS).In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA.METHODSIn total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA.In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters.RESULTSIn this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters.This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA.CONCLUSIONSThis study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA. Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS). In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA. In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters. This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA. Background Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS). Methods In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA. Results In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters. Conclusions This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA. Abstract Background Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS). Methods In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA. Results In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters. Conclusions This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA. Background Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms, and prognosis. Previous studies have analyzed the hemodynamic changes of the ophthalmic artery (OA) in patients with diabetes and ischemic heart disease, but the results remain controversial due to limited observation methods. We aimed to explore the morphological and hemodynamic features in the OA in patients with type 2 diabetes (T2D) with and without acute coronary syndrome (ACS). Methods In total, 134 participants, including 30 control participants, 34 with ACS only, 34 with T2D only, and 36 with both ACS and T2D, undergoing computed tomography angiography were enrolled. Three-dimensional OA models were reconstructed, and morphological parameters of the OA were measured. In addition, numerical simulations using computational fluid dynamics were used to acquire hemodynamic parameters of the OA. Results In this study, 134 OA models were reconstructed. Morphological measurements revealed a smaller initial OA diameter in the T2D group than in the other two ACS groups. A hemodynamic simulation showed a significantly lower OA blood velocity in patients with ACS and T2D than that in controls (P < 0.001). The mass flow ratios in all disease groups were lower than those in the control group (P < 0.001, P = 0.020, and P < 0.001, respectively). The ACS and T2D groups had higher OA pressure levels than those of the control group (P = 0.013). The OA blood velocity and mass flow ratio were correlated with several clinical parameters. Conclusions This study revealed morphological and hemodynamic differences in the OA between patients with T2D with and without ACS. Furthermore, the hemodynamic characteristics of the OA correlated with clinical prognostic biomarkers, suggesting the potential predictive ability of the OA. Keywords: Acute coronary syndrome, Computational fluid dynamics, Hemodynamic numerical simulation, Ophthalmic artery, Type 2 diabetes |
ArticleNumber | 512 |
Audience | Academic |
Author | Wang, Jia-lin Wu, Lan-ting Wang, Yan-ling |
Author_xml | – sequence: 1 givenname: Lan-ting orcidid: 0000-0002-5990-5926 surname: Wu fullname: Wu, Lan-ting – sequence: 2 givenname: Jia-lin orcidid: 0000-0001-7877-1620 surname: Wang fullname: Wang, Jia-lin – sequence: 3 givenname: Yan-ling orcidid: 0000-0002-7191-6660 surname: Wang fullname: Wang, Yan-ling |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36335387$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kl1rHCEUhqWkNMm2f6AXZaA3vZnUj1HHm0II_QgEctNci6POrsusbtVpyb_v2d00zYZSBD0cn_Pq0fccncQUPUJvCb4gpBcfC6FKyBZT2mImCcwv0BnppGp5L8XJk_gUnZeyxph2vFOv0CkTjHHWyzN0d7td1ZWZNsE2Jlef7xu7MnHpSxNiU--3vqGNC2bwFVK_Ql01Jrp9kObaGDtX39iUUzRQWu6jy2njX6OXo5mKf_OwLtDdl8_fr761N7dfr68ub1rLBautlM5JbwyXnXFu6HrsBiwHhZUy48C6kUo5QM4o0hMhLew44pgcscCdEpQt0PVB1yWz1tscNnALnUzQ-0TKSw1NBTt5PXAllHcjIYZ21rCBdyAAx2BCu0H2oPXpoLWdh4131seazXQkerwTw0ov00-tBBOCcBD48CCQ04_Zl6o3oVg_TSb6NBdNJaOccYkZoO-foes05whPtaOk5D3p6V9qaaCBEMcE59qdqL6UlBOJe0WAuvgHBcN5-FRwzBggf1Tw7mmjjx3-MQUA9ADYnErJfnxECNY75-mD8zQ4T--dB_MC9c-KbKimhrR7rDD9r_Q3U87bqQ |
CitedBy_id | crossref_primary_10_3390_diagnostics13233514 crossref_primary_10_1002_jum_16598 |
Cites_doi | 10.1155/2021/4946711 10.1111/j.1755-3768.2011.02178.x 10.1038/s41433-020-01173-7 10.1007/s10143-006-0028-6 10.1016/j.amjmed.2020.07.013 10.1007/s00417-014-2896-8 10.1016/j.ijbiomac.2020.01.168 10.1007/s001250051296 10.1111/jdi.12545 10.1016/S0140-6736(09)62124-3 10.1186/s12872-018-0806-4 10.1167/iovs.13-11763 10.1093/eurheartj/ehy822 10.1161/CIRCRESAHA.115.306301 10.3171/2019.5.FOCUS19234 10.1111/aos.12102 10.1016/j.exer.2015.12.011 10.1016/S0014-4835(02)00312-3 10.1016/j.exer.2006.03.024 10.1016/j.mvr.2009.12.007 10.1155/2018/7126532 10.2337/dc18-1390 10.1093/cvr/cvy174 10.4103/1793-5482.106643 10.1182/blood-2006-12-027698 10.1186/s12933-017-0534-6 10.1900/RDS.2012.9.104 10.1177/1479164118780799 10.3389/fcvm.2021.769343 10.1136/bjophthalmol-2013-304224 10.1016/j.jbiomech.2015.11.009 10.1186/s12933-018-0793-x 10.1002/ejhf.1359 10.1161/01.STR.22.6.711 10.1016/j.survophthal.2008.10.003 10.3390/ijms19061663 10.1016/j.bpj.2018.08.031 10.1186/s12933-018-0728-6 10.1001/jama.298.7.765 10.1167/iovs.62.14.7 10.3390/antiox11040617 10.4103/ijo.IJO_1398_19 10.1186/s12886-016-0217-1 10.1167/iovs.06-1280 10.1016/j.ophtha.2006.03.028 10.4103/JMU.JMU_88_20 10.1093/eurheartj/ehx810 10.1001/jamacardio.2016.2049 |
ContentType | Journal Article |
Copyright | 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2022 |
Copyright_xml | – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2022 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12967-022-03712-0 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1479-5876 |
EndPage | 10 |
ExternalDocumentID | oai_doaj_org_article_b5969edf11a24ca3b54623afb0124b78 PMC9636615 A725170891 36335387 10_1186_s12967_022_03712_0 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China Beijing China United States--US |
GeographicLocations_xml | – name: China – name: Beijing China – name: United States--US |
GrantInformation_xml | – fundername: ; grantid: yyqdkt 2019-29 – fundername: ; grantid: No.81870686 – fundername: ; grantid: 202103 – fundername: ; grantid: No. 2018-1-2021 |
GroupedDBID | --- 0R~ 29L 2WC 53G 5VS 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7T5 7XB 8FK AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c563t-77dd7eaa574addb480db07b9099afb34f277b0dba918167cb90d1d37f06049623 |
IEDL.DBID | M48 |
ISSN | 1479-5876 |
IngestDate | Wed Aug 27 01:26:09 EDT 2025 Thu Aug 21 18:39:50 EDT 2025 Fri Jul 11 03:17:47 EDT 2025 Fri Jul 25 06:08:09 EDT 2025 Tue Jun 17 21:34:09 EDT 2025 Tue Jun 10 20:25:41 EDT 2025 Thu Jan 02 22:55:16 EST 2025 Thu Apr 24 22:52:13 EDT 2025 Tue Jul 01 02:59:37 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Type 2 diabetes Ophthalmic artery Computational fluid dynamics Acute coronary syndrome Hemodynamic numerical simulation |
Language | English |
License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c563t-77dd7eaa574addb480db07b9099afb34f277b0dba918167cb90d1d37f06049623 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-7191-6660 0000-0001-7877-1620 0000-0002-5990-5926 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12967-022-03712-0 |
PMID | 36335387 |
PQID | 2737758182 |
PQPubID | 43076 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b5969edf11a24ca3b54623afb0124b78 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9636615 proquest_miscellaneous_2732535703 proquest_journals_2737758182 gale_infotracmisc_A725170891 gale_infotracacademiconefile_A725170891 pubmed_primary_36335387 crossref_primary_10_1186_s12967_022_03712_0 crossref_citationtrail_10_1186_s12967_022_03712_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-11-05 |
PublicationDateYYYYMMDD | 2022-11-05 |
PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-05 day: 05 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Journal of translational medicine |
PublicationTitleAlternate | J Transl Med |
PublicationYear | 2022 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | T Zhang (3712_CR20) 2015; 253 V Kanagaraju (3712_CR10) 2021; 29 K Divya (3712_CR11) 2020; 68 F Molica (3712_CR30) 2018 TR Einarson (3712_CR1) 2018; 17 M Karami (3712_CR9) 2012; 9 J Raffort (3712_CR27) 2018; 114 SM Donahoe (3712_CR2) 2007; 298 N Dattani (3712_CR26) 2018; 15 J Lu (3712_CR48) 2019; 42 SP Jackson (3712_CR38) 2007; 109 L Chodari (3712_CR36) 2021; 2021 GM Rubanyi (3712_CR47) 1990; 27 C Sun (3712_CR8) 2009; 54 R Carpi-Santos (3712_CR33) 2022 D Arun (3712_CR28) 2021; 8 J Febina (3712_CR15) 2018; 2018 R Allon (3712_CR29) 2021; 134 G Franck (3712_CR41) 2019; 40 I Stalmans (3712_CR12) 2011; 89 K Polak (3712_CR24) 2003; 76 HY Chang (3712_CR39) 2018; 115 V Thondapu (3712_CR13) 2018; 39 MR Sterling (3712_CR49) 2018; 18 P Krasnicki (3712_CR5) 2014; 98 M Kojima (3712_CR17) 2012; 7 B Guerciotti (3712_CR14) 2016; 49 T von Hanno (3712_CR6) 2014; 92 M Zhou (3712_CR3) 2018; 17 X Luo (3712_CR25) 2015; 2015 LT Wu (3712_CR16) 2021; 62 G Querques (3712_CR44) 2021; 35 M Kanwar (3712_CR35) 2007; 48 R Rørth (3712_CR50) 2019; 21 R Klein (3712_CR22) 2006; 113 A Eftekhari (3712_CR31) 2020; 148 J Frösen (3712_CR46) 2019; 47 D Deng (3712_CR23) 1999; 42 N Cheung (3712_CR43) 2010; 376 A Eisen (3712_CR42) 2016; 1 Y Dong (3712_CR21) 2016; 16 T Tien (3712_CR32) 2013; 54 R Heitmar (3712_CR4) 2017; 16 T Tien (3712_CR7) 2016; 146 NASCE Trial (3712_CR18) 1991; 22 S Erdogmus (3712_CR19) 2006; 29 S Kralev (3712_CR45) 2010; 79 T Umemura (3712_CR37) 2017; 8 MA Gimbrone Jr (3712_CR40) 2016; 118 Y Cui (3712_CR34) 2006; 83 |
References_xml | – volume: 2021 start-page: 4946711 year: 2021 ident: 3712_CR36 publication-title: Oxid Med Cell Longev doi: 10.1155/2021/4946711 – volume: 89 start-page: e609 year: 2011 ident: 3712_CR12 publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2011.02178.x – volume: 35 start-page: 142 year: 2021 ident: 3712_CR44 publication-title: Eye doi: 10.1038/s41433-020-01173-7 – volume: 29 start-page: 213 year: 2006 ident: 3712_CR19 publication-title: Neurosurg Rev doi: 10.1007/s10143-006-0028-6 – volume: 134 start-page: 36 year: 2021 ident: 3712_CR29 publication-title: Am J Med doi: 10.1016/j.amjmed.2020.07.013 – volume: 253 start-page: 627 year: 2015 ident: 3712_CR20 publication-title: Graefes Arch Clin Exp Ophthalmol doi: 10.1007/s00417-014-2896-8 – volume: 148 start-page: 475 year: 2020 ident: 3712_CR31 publication-title: Int J Biol Macromol doi: 10.1016/j.ijbiomac.2020.01.168 – volume: 42 start-page: 1228 year: 1999 ident: 3712_CR23 publication-title: Diabetologia doi: 10.1007/s001250051296 – volume: 8 start-page: 134 year: 2017 ident: 3712_CR37 publication-title: J Diabetes Investig doi: 10.1111/jdi.12545 – volume: 376 start-page: 124 year: 2010 ident: 3712_CR43 publication-title: Lancet doi: 10.1016/S0140-6736(09)62124-3 – volume: 2015 year: 2015 ident: 3712_CR25 publication-title: J Ophthalmol – volume: 18 start-page: 66 year: 2018 ident: 3712_CR49 publication-title: BMC Cardiovasc Disord doi: 10.1186/s12872-018-0806-4 – volume: 54 start-page: 6518 year: 2013 ident: 3712_CR32 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.13-11763 – volume: 40 start-page: 928 year: 2019 ident: 3712_CR41 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehy822 – volume: 118 start-page: 620 year: 2016 ident: 3712_CR40 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.115.306301 – volume: 47 start-page: E21 year: 2019 ident: 3712_CR46 publication-title: Neurosurg Focus doi: 10.3171/2019.5.FOCUS19234 – volume: 92 start-page: 40 year: 2014 ident: 3712_CR6 publication-title: Acta Ophthalmol doi: 10.1111/aos.12102 – volume: 146 start-page: 103 year: 2016 ident: 3712_CR7 publication-title: Exp Eye Res doi: 10.1016/j.exer.2015.12.011 – volume: 76 start-page: 633 year: 2003 ident: 3712_CR24 publication-title: Exp Eye Res doi: 10.1016/S0014-4835(02)00312-3 – volume: 83 start-page: 807 year: 2006 ident: 3712_CR34 publication-title: Exp Eye Res doi: 10.1016/j.exer.2006.03.024 – volume: 79 start-page: 150 year: 2010 ident: 3712_CR45 publication-title: Microvasc Res doi: 10.1016/j.mvr.2009.12.007 – volume: 2018 start-page: 7126532 year: 2018 ident: 3712_CR15 publication-title: Comput Math Methods Med doi: 10.1155/2018/7126532 – volume: 42 start-page: 1539 year: 2019 ident: 3712_CR48 publication-title: Diabetes Care doi: 10.2337/dc18-1390 – volume: 114 start-page: 1702 year: 2018 ident: 3712_CR27 publication-title: Cardiovasc Res doi: 10.1093/cvr/cvy174 – volume: 7 start-page: 159 year: 2012 ident: 3712_CR17 publication-title: Asian J Neurosurg doi: 10.4103/1793-5482.106643 – volume: 109 start-page: 5087 year: 2007 ident: 3712_CR38 publication-title: Blood doi: 10.1182/blood-2006-12-027698 – volume: 16 start-page: 56 year: 2017 ident: 3712_CR4 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-017-0534-6 – volume: 9 start-page: 104 year: 2012 ident: 3712_CR9 publication-title: Rev Diabet Stud doi: 10.1900/RDS.2012.9.104 – volume: 15 start-page: 367 year: 2018 ident: 3712_CR26 publication-title: Diab Vasc Dis Res doi: 10.1177/1479164118780799 – volume: 8 year: 2021 ident: 3712_CR28 publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2021.769343 – volume: 98 start-page: 675 year: 2014 ident: 3712_CR5 publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2013-304224 – volume: 49 start-page: 26 year: 2016 ident: 3712_CR14 publication-title: J Biomech doi: 10.1016/j.jbiomech.2015.11.009 – volume: 17 start-page: 147 year: 2018 ident: 3712_CR3 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-018-0793-x – volume: 21 start-page: 40 year: 2019 ident: 3712_CR50 publication-title: Eur J Heart Fail doi: 10.1002/ejhf.1359 – volume: 22 start-page: 711 year: 1991 ident: 3712_CR18 publication-title: Stroke doi: 10.1161/01.STR.22.6.711 – volume: 54 start-page: 74 year: 2009 ident: 3712_CR8 publication-title: Surv Ophthalmol doi: 10.1016/j.survophthal.2008.10.003 – year: 2018 ident: 3712_CR30 publication-title: Int J Mol Sci doi: 10.3390/ijms19061663 – volume: 115 start-page: 1371 year: 2018 ident: 3712_CR39 publication-title: Biophys J doi: 10.1016/j.bpj.2018.08.031 – volume: 17 start-page: 83 year: 2018 ident: 3712_CR1 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-018-0728-6 – volume: 298 start-page: 765 year: 2007 ident: 3712_CR2 publication-title: JAMA doi: 10.1001/jama.298.7.765 – volume: 62 start-page: 7 year: 2021 ident: 3712_CR16 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.62.14.7 – year: 2022 ident: 3712_CR33 publication-title: Antioxidants doi: 10.3390/antiox11040617 – volume: 27 start-page: 246 year: 1990 ident: 3712_CR47 publication-title: Blood Vessels – volume: 68 start-page: 1108 year: 2020 ident: 3712_CR11 publication-title: Indian J Ophthalmol doi: 10.4103/ijo.IJO_1398_19 – volume: 16 start-page: 43 year: 2016 ident: 3712_CR21 publication-title: BMC Ophthalmol doi: 10.1186/s12886-016-0217-1 – volume: 48 start-page: 3805 year: 2007 ident: 3712_CR35 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.06-1280 – volume: 113 start-page: 1488 year: 2006 ident: 3712_CR22 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2006.03.028 – volume: 29 start-page: 111 year: 2021 ident: 3712_CR10 publication-title: J Med Ultrasound doi: 10.4103/JMU.JMU_88_20 – volume: 39 start-page: 1602 year: 2018 ident: 3712_CR13 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehx810 – volume: 1 start-page: 718 year: 2016 ident: 3712_CR42 publication-title: JAMA Cardiol doi: 10.1001/jamacardio.2016.2049 |
SSID | ssj0024549 |
Score | 2.370854 |
Snippet | Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological mechanisms,... Background Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow, pathological... Abstract Background Ocular blood flow provides a new perspective for studying the effects of diabetes and ischemic heart disease on systemic blood flow,... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 512 |
SubjectTerms | Acute coronary syndrome Acute Coronary Syndrome - complications Acute Coronary Syndrome - diagnostic imaging Acute coronary syndromes Angiography Biomarkers Blood flow Cardiovascular disease Care and treatment Carotid artery Comorbidity Complications and side effects Computational fluid dynamics Computed tomography Computed Tomography Angiography Computer applications Coronary Angiography - methods Coronary Artery Disease Diabetes Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - complications Diabetic retinopathy Electronic health records Finite volume method Flow velocity Fluid dynamics Heart diseases Hemodynamic monitoring Hemodynamic numerical simulation Hemodynamics Hospitals Humans Ischemia Medical examination Medical records Methods Morphology Numerical analysis Observation methods Ophthalmic artery Ophthalmic Artery - diagnostic imaging Patients Prevention Risk factors Simulation Simulation methods Type 2 diabetes Veins & arteries Velocity Viscosity |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9swFH-MHsYuY93W1ms3NBj0UExtS7LkYzsWwqDbZYHehD5sEuic0DiH_fd9T7ZDzKC77GKCJYH19L7z3k8AX4Jy1Pit00Z6St24LLXS29SqotbSO5c7ynfc_SjnC_H9Xt4fXPVFNWE9PHBPuGsnq7KqQ5PnthDecicFWmzbONSswqnY5os2bwymRpQ9DHvGFhldXm_RqqFCoMp1gqjD58QMRbT-v3XygVGaFkweWKDZG3g9uI7spv_kY3hRt2_h5d3w5_g7WPzcLLulffi98ixWav5hfVvvlq1aRrlWVrAx18ooActsG-KP9a5j1u-6mnlCNLC4dIQyeA-L2bdfX-fpcGtC6mXJO3SXQ1C1tVIJ1F1O6Cy4TLkKXUGkGhdNofBEgrMVGvdSeRwJeeCqIRidCml7Akftuq3PgEndCMWrEJDAIohS59IKy3UmnERXySeQj0Q0foAUp5stHkwMLXRpesIbJLyJhDdZAlf7NZseUOPZ2bd0NvuZBIYdXyCLmIFFzL9YJIFLOllDIouf5-3QeYCbJPArc6MIty3TVZ7AxWQmipqfDo-8YQZR3xr0_xQGXRinJfB5P0wrqXytrde7OKeQnMDOEjjtWWm_JV5yjlZHJaAmTDbZ83SkXS0jEDgqT3Sv5If_QaRzeFWQfFDGXF7AUfe4qz-iv9W5T1G0ngDltiWQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9QwFH_oCuJF_La6SgTBg5Rtm6RJT7KKyyKsXhyYW8hH6wys7bjTOfjf-14mnd0i7GUokwT6kvfxy-vLLwDvg3J08FvnnfSUunFFbqW3uVVVq6V3rnSU77j4Xp8vxLelXKaE2zaVVU4-MTrqMHjKkZ9gmFWIbREOf9r8yenWKPq6mq7QuAv3iLqMtFotrzdcAjc_00EZXZ9sMbahW6D6dSKqw99ZMIqc_f975huhaV42eSMOnT2ChwlAstP9ij-GO23_BO5fpE_kT2HxY7MaV_by99qzWK_5l-0P927ZumeUcWUVmzKujNKwzPYhPgy7kVm_G1vmidfA4tCJ0OAZLM6-_vxynqe7E3Ivaz4iaA5BtdZKJdCDOaGL4ArlGgSEtnNcdJXCdQnONhjia-WxJZSBq47IdBrERM_hqB_69iUwqTuheBMCQgsRRK1LaYXluhBOImDyGZTTJBqfiMXpfotLEzcYujb7iTc48SZOvCky-HgYs9nTatza-zOtzaEnUWLHP4arXyZZmHGyqZs2dGVpK-Etd1KgGCgshmDhlM7gA62sIcPF1_M2nT9AIYkCy5wqYm8rdFNmcDzriQbn582Tbphk8FtzrZ4ZvDs000gqYuvbYRf7VJIT5VkGL_aqdBCJ15xj7FEZqJmSzWSet_TrVaQDRxeKIEu-uv21XsODijSfMuLyGI7Gq137BvHU6N5Go_kHVt4dJg priority: 102 providerName: ProQuest |
Title | Ophthalmic artery changes in type 2 diabetes with and without acute coronary syndrome |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36335387 https://www.proquest.com/docview/2737758182 https://www.proquest.com/docview/2732535703 https://pubmed.ncbi.nlm.nih.gov/PMC9636615 https://doaj.org/article/b5969edf11a24ca3b54623afb0124b78 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEB_uA8QX8dvquUQQfJDVfiRN-iByK3ccwp5yuLD4EvLR3i6s3XO3C95_70y2Xa94-ORLKE0CnclM5qPJbwBee2np4rcaVsJR6sbGQyOcGRqZlko4axNL-Y7xeX424Z-nYroHXbmjloHrW0M7qic1WS3e_fp5_REV_kNQeJW_X6PNQnWnc-kEQIftPhyiZZJU0WDM1R_sPQyGuoszt87rGaeA4f_3Tn3DVPWPUd6wS6f34V7rULLjrQQ8gL2yfgh3xu0v80cw-XI1a2Zm8WPuWDi_ec22l33XbF4zysCylHUZWEZpWWZqHx6Wm4YZt2lK5gjnwODUDuDgMUxOT759Ohu2tRSGTuRZg06097I0RkiOO5rlKvY2lrZAB9FUNuNVKnGdvDUFmvxcOuzxic9kReA6BfpIT-CgXtblM2BCVVxmhffoanDPc5UIw02mYm4FOlAugqRjonYt0DjVu1joEHCoXG8Zr5HxOjBexxG83c252sJs_HP0iNZmN5IgssOL5epStxqnrSjyovRVkpiUO5NZwZEMJBZNMrdSRfCGVlaTaOHnOdPeR0AiCRJLH0tCc4tVkURw1BuJCuj63Z1s6E5-NXqFEkMxjN4ieLXrppl0qK0ul5swJhUZQaBF8HQrSjuSsjzL0BbJCGRPyHo093vq-SzAg-OWik6XeP4_mPQC7qakH5RHF0dw0Kw25Uv0who7gH05lQM4HJ2cf70YhFzGIKgbthej778Br_IxwA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRQIuiHcDBYwE4oCiJrEdJweEyqPa0m65dKW9GT8SdqWSXbpZof4pfiMzeWwbIfXWSxTFtmSP5x3PZ4A3Xlkq_M7CUjpK3dgoNNKZ0KikyKSzNraU7xifpKOJ-DaV0y3429fC0LHKXic2itovHOXI99DMKvRt0R3-uPwd0q1R9He1v0KjZYuj4uIPhmyrD4dfcH_fJsnB19PPo7C7VSB0MuU1upPeq8IYqQTKthVZ5G2kbI6ukiktF2WicMbemhyNX6octvjYc1USzEyeEtABqvxbaHgjCvbU9DLAExhs9YU5Wbq3QluKaojOyxMwHj4Hxq-5I-B_S3DFFA6PaV6xewf34V7nsLL9lsMewFZRPYTb4-6X_COYfF_O6pk5-zV3rDkfesHaYuIVm1eMMrwsYX2Gl1Hal5nKNy-Ldc2MW9cFc4SjYHBoD6DwGCY3QtUnsF0tqmIHmMxKoXjuPboywos0i6URhmeRsBIdNBdA3BNRuw7InO7TONNNQJOluiW8RsLrhvA6CuD9ZsyyhfG4tvcn2ptNT4Lgbj4szn_qTqK1lXmaF76MY5MIZ7iVApeBi0WTL6zKAnhHO6tJUeD0nOnqHXCRBLml9xWhxUVZHgewO-iJAu6GzT1v6E7BrPSlOATwetNMI-nQXFUs1k2fRHKCWAvgactKmyXxlHO0dSoANWCywZqHLdV81sCPo8pGp04-u35ar-DO6HR8rI8PT46ew92EpICy8XIXtuvzdfECfbnavmwEiMGPm5bYfyAbWis |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ophthalmic+artery+changes+in+type+2+diabetes+with+and+without+acute+coronary+syndrome&rft.jtitle=Journal+of+translational+medicine&rft.au=Lan-ting+Wu&rft.au=Jia-lin+Wang&rft.au=Yan-ling+Wang&rft.date=2022-11-05&rft.pub=BMC&rft.eissn=1479-5876&rft.volume=20&rft.issue=1&rft.spage=1&rft.epage=10&rft_id=info:doi/10.1186%2Fs12967-022-03712-0&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_b5969edf11a24ca3b54623afb0124b78 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon |